United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News FDA approves expansive label updates for Esperion’s NEXLETOL and NEXLIZET In a significant advancement for heart health management, Esperion (NASDAQ: ESPR) has announced that the United States Food… byPallavi MadhirajuMarch 23, 2024